Evidence map›Paper›PMID 21325597›Full record

ArticleBlood2011

Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis.

Janos Sumegi, Michael G Barnes, Shawnagay V Nestheide, Susan Molleran-Lee, Joyce Villanueva, Kejian Zhang, Kimberly A Risma, Alexei A Grom, Alexandra H Filipovich

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01547143 (Pilot Study of First-line Immunosuppressive Therapy Combined With Etoposide and Allogeneic Hematopoietic Cell Transplantation in Refractory/Reactivated Cases for Hemophagocytic Lymphohistiocytosis), which is not on this map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01547143 naterminatednot on this mapstarted 2012, after this paper: background citation

Pilot Study of First-line Immunosuppressive Therapy Combined With Etoposide and Allogeneic Hematopoietic Cell Transplantation in Refractory/Reactivated Cases for Hemophagocytic Lymphohistiocytosis (HLH) in Adult Patients

TypeinterventionalSponsorAsan Medical CenterRan2012 to 2016Enrolled12ConditionsHemophagocytic LymphohistiocytosisArmsIST and/or alloHCT
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.Advances in experimental medicine and biology · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Seizure and COVID-19: Association and review of potential mechanism.Neurology, psychiatry, and brain research · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Janos SumegiDivision of Bone Marrow Transplantation and Immunodeficiency, Cincinnati Children’s Hospital Medical Center, University of Cincinnati Faculty of Medicine, Cincinnati, OH, USA.
Michael G Barnes
Shawnagay V Nestheide
Susan Molleran-Lee
Joyce Villanueva
Kejian Zhang
Kimberly A Risma
Alexei A Grom
Alexandra H Filipovich
National Marrow Donor Program · USInstitute of Human Genetics · PLUniversity of Cincinnati · US

Funding

Identification of Genes Involved in FHLHR21AI076746 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI SUMEGI, JANOS · 2009 to 2010
$418k
Functional Identification of Genes Mutated in FHLHR21AI079759 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI SUMEGI, JANOS · 2008 to 2009
$413k
NIAID NIH HHS R21 AI076746NIAID NIH HHS R21 AI076746-01NIAID NIH HHS R21 AI079759NIAID NIH HHS R21AI079759-02
6 · The paper itself

Abstract

Familial hemophagocytic lymphohistiocytosis (FHL) is a rare, genetically heterogeneous autosomal recessive immune disorder that results when the critical regulatory pathways that mediate immune defense mechanisms and the natural termination of immune/inflammatory responses are disrupted or overwhelmed. To advance the understanding of FHL, we performed gene expression profiling of peripheral blood mononuclear cells from 11 children with untreated FHL. Total RNA was isolated and gene expression levels were determined using microarray analysis. Comparisons between patients with FHL and normal pediatric controls (n = 30) identified 915 down-regulated and 550 up-regulated genes with more than or equal to 2.5-fold difference in expression (P ≤ .05). The expression of genes associated with natural killer cell functions, innate and adaptive immune responses, proapoptotic proteins, and B- and T-cell differentiation were down-regulated in patients with FHL. Genes associated with the canonical pathways of interleukin-6 (IL-6), IL-10 IL-1, IL-8, TREM1, LXR/RXR activation, and PPAR signaling and genes encoding of antiapoptotic proteins were overexpressed in patients with FHL. This first study of genome-wide expression profiling in children with FHL demonstrates the complexity of gene expression patterns, which underlie the immunobiology of FHL.

Indexed as

Gene Expression ProfilingB-LymphocytesChild, PreschoolFemaleHumansInterleukin-1Interleukin-10Interleukin-6Interleukin-8Killer Cells, NaturalLeukocytes, MononuclearLiver X ReceptorsLymphohistiocytosis, HemophagocyticMaleMembrane GlycoproteinsOligonucleotide Array Sequence AnalysisCXCL8 protein, humanIL10 protein, humanIL6 protein, humanInterleukin-1Interleukin-10Interleukin-6Interleukin-8Liver X ReceptorsMembrane GlycoproteinsOrphan Nuclear ReceptorsPerforinPeroxisome Proliferator-Activated ReceptorsReceptors, ImmunologicRetinoid X Receptor alphaTREM1 protein, humanTriggering Receptor Expressed on Myeloid Cells-1

Identifiers

PMID21325597
PMCPMC3087540
OpenAlexW2169555023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.